Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-01-12 @ 5:19 AM
Study NCT ID:
NCT04747002
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2021-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.
Sponsor:
Osaka University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WT1-AM-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER_GOV | View |